BRIACELL THERAP EPS Growth (basic)

EPS Growth (basic) of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (basic) growth rates and interactive chart. Year over year growth in basic earnings per share.


Highlights and Quick Summary

  • EPS Growth (basic) for the quarter ending October 31, 2022 was 59.27% (a -122.5% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (basic) increased by 35.72%
  • Annual EPS Growth (basic) for 2022 was -1822.22% (a -1954.3% decrease from previous year)
  • Annual EPS Growth (basic) for 2021 was 98.27% (a 592.53% increase from previous year)
  • Annual EPS Growth (basic) for 2020 was 14.19% (a -57.44% decrease from previous year)
  • Twelve month EPS Growth (basic) ending October 31, 2022 was -325.9% (a 182.16% increase compared to previous quarter)
  • Twelve month trailing EPS Growth (basic) decreased by -443.38% year-over-year
Trailing EPS Growth (basic) for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
-325.9% -115.5% 95.55% 94.91%
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (basic) of BRIACELL THERAP

Most recent EPS Growth (basic)of BCTX including historical data for past 10 years.

Interactive Chart of EPS Growth (basic) of BRIACELL THERAP

BRIACELL THERAP EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 59.27% -263.46% 23.17% 43.67% -1822.22%
2021 72.19% 173.56% 79.4% 98.27%
2020 99.92% 80.86% 72.28% 34.33% 14.19%
2019 -18100.18% 50.0% 0.0% 0.0% 33.34%
2018 0.0% -100.0% 0.0% 0.0% -50.0%
2017 0.0% 0.0% 0.0% 0.0% 0.0%
2016 0.0% 100.0% 100.0% 0.0% 15.83%
2015 0.0%

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology